TNF Pharmaceuticals (TNFA) said Wednesday it has received a Nasdaq notice that it has regained compliance with the exchange's minimum bid price requirement.
To regain compliance, the company's shares maintained the minimum bid price of $1.00 for 10 consecutive business days, TNF Pharmaceuticals said.
TNF shares were 2.8% higher in early recent trading.
Price: 4.10, Change: +0.15, Percent Change: +3.80
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.